CR6773A - VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA - Google Patents

VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA

Info

Publication number
CR6773A
CR6773A CR6773A CR6773A CR6773A CR 6773 A CR6773 A CR 6773A CR 6773 A CR6773 A CR 6773A CR 6773 A CR6773 A CR 6773A CR 6773 A CR6773 A CR 6773A
Authority
CR
Costa Rica
Prior art keywords
myeloencephalitis
equina
protozoal
vaccine against
inactivated
Prior art date
Application number
CR6773A
Other languages
Spanish (es)
Inventor
Barry Bigbie Rocky
Wilson Jr Whalen Joseph
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Priority to CR6773A priority Critical patent/CR6773A/en
Publication of CR6773A publication Critical patent/CR6773A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invencion proporciona un componente inmunogenicamente activo que comprende celulas de Sarcocystis neurona inactivadas y/ o celulas inactivadas de Neospora hughesi; derivados de antigenos de estas, ADN derivado de estas; o una mezcla; o en combinacion con otros componentes de vacunas contra dichos agentes infecciosos. Se proprociona ademas composiciones de vacunas utiles para prevenir o aliviar la infeccion y enfermedad de la mieloencefalitis protozoaria equina y un metodo para la propagacion de parasitos protozoarios en cultivos de celulas.The present invention provides an immunogenically active component comprising inactivated Sarcocystis neuron cells and / or inactivated Neospora hughesi cells; antigen derivatives thereof, DNA derived therefrom; or a mixture; or in combination with other components of vaccines against said infectious agents. In addition, useful vaccine compositions are provided to prevent or alleviate infection and disease of equine protozoan myeloencephalitis and a method for the propagation of protozoan parasites in cell cultures.

CR6773A 2002-10-08 2002-10-08 VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA CR6773A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR6773A CR6773A (en) 2002-10-08 2002-10-08 VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR6773A CR6773A (en) 2002-10-08 2002-10-08 VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA

Publications (1)

Publication Number Publication Date
CR6773A true CR6773A (en) 2006-05-30

Family

ID=44839071

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6773A CR6773A (en) 2002-10-08 2002-10-08 VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA

Country Status (1)

Country Link
CR (1) CR6773A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10864260B2 (en) 2015-10-28 2020-12-15 Universidad Complutense De Madrid Neospora vaccine composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10864260B2 (en) 2015-10-28 2020-12-15 Universidad Complutense De Madrid Neospora vaccine composition

Similar Documents

Publication Publication Date Title
Marzi et al. Vesicular stomatitis virus–based vaccines against lassa and ebola viruses
EA200900784A1 (en) VACCINES INCLUDING ANTIGENS FROM FOUR STRAINS OF THE INFLUENZA VIRUS
Van Den Hurk et al. Impact of Wolbachia on infection with chikungunya and yellow fever viruses in the mosquito vector Aedes aegypti
EA200801221A1 (en) VIRAL VACCINES OBTAINED FROM CELLS WITH LOW LEVELS OF RESIDUAL CELL DNA
CY1106785T1 (en) VIRUS PARTICLES RELEASED AFTER HUMAN CYTOmegalovirus INFECTION AND THEIR USE AS A VACCINE
NO20023829D0 (en) Proteosome influenza vaccine
ES2546403T3 (en) Recombinant classical swine fever virus (VFPC) comprising a modified E2 protein and methods for generating said recombinant VFPC
ECSP045300A (en) VIRAL ANTIGENS
CY1116491T1 (en) VACCINES AGAINST FOLLOWING Fever
DE60142615D1 (en) EPITOP SYNCHRONIZATION IN ANY PRESENTING CELLS
WO2003079757A3 (en) Hiv therapeutic
BRPI0407636A (en) cell culture medium, animal cell lineage, methods for producing a conditioned culture medium, animal cells, an animal cell culture, virus in an animal cell culture, or preferably anchor-dependent diploid human, method for produce a vaccine, and virus population
DE60110822D1 (en) PREPARING FOR IMMUNIZING AGAINST THE AIDS VIRUS
CR8638A (en) AGALACTIAE ESTREPTOCOCOS VACCINE
HRP20040195B1 (en) West nile vaccine
AR036125A1 (en) MYCOPLASMA BOVIS VACCINE METHODS TO REDUCE PNEUMONIA IN ANIMALS; VACCINE AND KIT SAID PREPARATION PROCEDURE
AR057225A1 (en) VACCINES MARKED AGAINST THE VIRUS OF VIRICA BOVINA VIRUS
AR056712A1 (en) COMPOSITION AND EFFECTIVE VACCINE TO TREAT TO PREVENT OR IMPROVE THE INOCULATION OF THE CANINE INFLUENZA VIRUS METHOD TO GENERATE AN IMMUNOGEN OF THE EQUINE INFLUENZA VIRUS OR OF THE VIRUS INFLUENZA MODEL OF THE USE OF THE CONTACT US TO DETERMINE THE COMPACT
WO2009032913A3 (en) Thermal inactivation of rotavirus
WO2006029029A3 (en) Compositions for detection of latent hiv reactivation and methods of using the same
ATE493495T1 (en) GENETELY ENGINEERED CO-EXPRESSION DNA VACCINES, METHODS OF PRODUCTION THEREOF AND USES THEREOF
CR6773A (en) VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA
DK1578959T3 (en) Immunization of fish against viral infection
Payne Introduction to animal viruses
ES2100893T3 (en) PREPARATION PROCEDURE OF A VACCINE OR TOXIC AGENT.